NLM Logo

aflibercept MeSH Supplementary Concept Data 2021


MeSH Supplementary
aflibercept
Unique ID
C533178
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C533178
Entry Term(s)
AVE 0005
AVE 005
AVE-0005
AVE-005
AVE0005
AVE005
VEGF Trap - regeneron
VEGF Trap-Eye
VEGF-Trap
ZIV-aflibercept
Zaltrap
eylea
Pharm Action
Angiogenesis Inhibitors
Registry Number
15C2VL427D
Heading Mapped to
*Recombinant Fusion Proteins
*Receptors, Vascular Endothelial Growth Factor
Frequency
1676
Note
has antiangiogenic activity; consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders
Source
Drugs R D 2008;9(4):261-9
Date of Entry
2008/11/27
Revision Date
2021/01/12
aflibercept Preferred
eylea Narrower
Zaltrap Narrower
AVE 0005 Narrower
AVE 005 Narrower
ZIV-aflibercept Narrower
page delivered in 0.004s